Samtani, Mahesh N.

Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic

Samtani, M. N., Vermeulen, A., & Stuyckens, K. (2009) · Clinical Pharmacokinetics

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 170

Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ ‐64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose‐ranging study

Alba, M., Yee, J., Frustaci, M. E., Samtani, M. N., & Fleck, P. (2021) · Clinical Obesity

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 100

The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials

Raghavan, N., Samtani, M. N., Farnum, M., Yang, E., Novak, G., Grundman, M., Narayan, V., DiBernardo, A., & Initiative, A. D. N. (2013) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 96

Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3‐month formulation in patients with schizophrenia: A phase‐1, single‐dose, randomized, open‐label study

Ravenstijn, P., Remmerie, B., Savitz, A., Samtani, M. N., Nuamah, I., Chang, C., De Meulder, M., Hough, D., & Gopal, S. (2016) · The Journal of Clinical Pharmacology

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 86

A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

Coppola, D., Liu, Y., Gopal, S., Remmerie, B., Samtani, M. N., Hough, D. W., Nuamah, I., Sulaiman, A., & Pandina, G. (2012) · BMC Psychiatry

Schizophrenia research and treatmentPharmacogenetics and Drug Metabolism

Cited by 61

Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ‐64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose‐ranging study

Di Prospero, N. A., Yee, J., Frustaci, M. E., Samtani, M. N., Alba, M., & Fleck, P. (2021) · Clinical Obesity

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 60

Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month Formulations

Russu, A., Savitz, A., Mathews, M., Gopal, S., Feng, Y., & Samtani, M. N. (2019) · Journal of Clinical Psychopharmacology

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 8